SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.…
SL Science Holding Limited Reports First Half 2026 Financial Results
SL Science Holding (NASDAQ: SLBT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 14 employees.
The shares were at 0.5500 USD on 20 November 2026, down 94.7% over 52 weeks. Its 52-week range is 0.5141 USD to 14.50 USD: the price is 96.2% below the high and 7.0% above the low.
Its market capitalisation is 308.42M USD.
SL Science Holding reports return on equity of -167.2%, an operating margin of -70.6% and revenue down 7.6% year over year.
It holds more cash than debt, a net cash position of 3.07M USD. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.